The diagnosis of asbestosis in the 21^st century: a clinicopathological correlation of 102 cases

References

• Roggli VL, Gibbs AR, Attanoos R, Churg A, Popper H, Cagle P, et al. Pathology of asbestosis— An update of the diagnostic criteria: report of the asbestosis committee of the College of American Pathologists and Pulmonary Pathology Society. Arch Pathol Lab Med. 2010;134(3):462–480. doi:10.5858/134.3.462.
   PubMed Web of Science ®Google Scholar
• Sporn TA, Roggli VL. Asbestosis. In: Oury T, Sporn T Roggli V, eds. Pathology of Asbestos-Associated Diseases. 3rd ed. New York, NY: Springer; 2014:53–80.
   Google Scholar
• Roggli VL, Sharma A. Analysis of tissue mineral fiber content. In: Oury T, Sporn T, and , eds. Pathology of Asbestos-Associated Diseases. 3rd ed. New York, NY: Springer; 2014:253–292.
   Google Scholar
• Schneider F, Sporn TA, Roggli VL. Asbestos fiber content of lungs with diffuse interstitial fibrosis: an analytical scanning electron microscopic analysis of 249 cases. Arch Pathol Lab Med. 2010;134(3):457–461. doi:10.5858/134.3.457.
   PubMed Web of Science ®Google Scholar
• Pavlisko EN, Liu B, Green C, Sporn TA, Roggli VL. Malignant diffuse mesothelioma in women. A study of 354 cases. Am J Surg Pathol. 2020;44(3):293–304. doi:10.1097/PAS.0000000000001418.
   PubMed Web of Science ®Google Scholar
• Roggli VL, Vollmer RT. 25 years of fiber analysis: what have we learned? Hum Pathol. 2008;39(3):307–315. doi:10.1016/j.humpath.2007.07.005.
   PubMed Web of Science ®Google Scholar
• Tossavainen, A. Asbestos, asbestosis, and cancer: the Helsinki criteria for diagnosis and attribution. A consensus report of an international expert group. Scand J Work Environ Health. 1997;23:311–316.
   PubMed Web of Science ®Google Scholar
• Manni ML, Oury TD. Benign asbestos related pleural diseases. In: Oury T, Sporn T, and Roggli V, eds. Pathology of Asbestos-Associated Diseases. 3rd ed. New York, NY: Springer; 2014:141–156.
   Google Scholar
• Husain AN, Colby TV, Ordonez NG, Allen TC, Attanoos RL, Beasley MB, et al. Guidelines for pathologic diagnosis of malignant mesothelioma: 2017 update of the consensus statement from the International mesothelioma Interest Group. Arch Pathol Lab Med. 2018;142(1):89–108. doi:10.5858/arpa.2017-0124-RA.
   PubMed Web of Science ®Google Scholar
• Parkin M, Tyczynski JE, Boffetta P, Samet J, Shields P, Caporaso N. Lung cancer epidemiology and etiology. In: Travis W, Brambilla E, Burke A, Marx A Nicholson A, eds. WHO Classification of Tumours of the Lung, Pleura, Thymus and Heart. 4th ed. Lyon, France: IARC; 2015:12–15.
   Google Scholar
• Pavlisko EN, Sporn TA. Mesothelioma. In: Oury T, Sporn T, and Roggli V, eds. Pathology of Asbestos-Associated Diseases. 3rd ed. New York, NY: Springer; 2014:81–140.
   Google Scholar
• Roggli VL. Carcinoma of the lung. In: Oury T, Sporn T, and Roggli V, eds. Pathology of Asbestos-Associated Diseases. 3rd ed. New York, NY: Springer; 2014:157–176.
   Google Scholar
• Roggli VL. Asbestos bodies and non-asbestos ferruginous bodies. In: Oury T, Sporn T, and Roggli V, eds. Pathology of Asbestos-Associated Diseases. 3rd ed. New York, NY: Springer; 2014:25–51.
   Google Scholar
• Srebro SH, Roggli VL, Samsa GP. Malignant mesothelioma associated with low pulmonary tissue asbestos burdens: a light and scanning electron microscopic analysis of 18 cases. Mod Pathol. 1995;8:614–621.
   PubMed Web of Science ®Google Scholar
• Sporn TA, Roggli VL. Mineralogy of asbestos. In: Oury T, Sporn T, and Roggli V, eds. Pathology of Asbestos-Associated Diseases. 3rd ed. New York, NY: Springer; 2014:1–10.
   Google Scholar
• Roggli VL, Green CL. Dimensions of elongated mineral particles: a study of more than 570 fibers from more than 90 cases with implications for pathogenicity and classification as asbestiform vs. cleavage fragments. Ultrastruct Pathol. 2019;43(1):1–5. doi:10.1080/01913123.2019.1566298.
   PubMed Web of Science ®Google Scholar
• Roggli VL. Nonasbestos mineral fibers from human lungs. In: Russel P, ed. Microbeam Analysis. San Francisco, CA: San Francisco Press; 1989:57–59.
   Google Scholar
• Sporn T, Roggli VL. Occupational lung disease. In: Hasleton P Flieder D, eds. Spencer’s Pathology of the Lung. 6th ed. Cambridge: Cambridge University Press; 2013:512–562.
   Google Scholar
• Honma K, Abraham JL, Chiyotani K, DeVust P, Dumorteir P, Gibbs AR, et al. Proposed criteria for mixed-dust pneumoconiosis: definition, descriptions, and guidelines for pathologic diagnosis and clinical correlation.Human Pathol. 2004;35(12):1515–1523. doi:10.1016/j.humpath.2004.09.008.
   PubMed Web of Science ®Google Scholar
• Roggli VL, Sharma A, Butnor KJ, Sporn T, Vollmer RT. Malignant mesothelioma and occupational exposure to asbestos: a clinical pathological correlation of 1445 cases. Ultrastruc Pathol. 2002;26(2):55–65. doi:10.1080/01913120252959227.
   PubMed Web of Science ®Google Scholar
• Srebro SH, Roggli VL. Asbestos-related disease associated with exposure to asbestiform tremolite. Am J Ind Med. 1994;26(6):809–819. doi:10.1002/ajim.4700260610.
   PubMed Web of Science ®Google Scholar
• Klebe S, Brownlee NA, Mahar A, Burchette JL, Sporn TA, Vollmer RT. Sarcomatoid mesothelioma: a clinical–pathologic correlation of 326 cases. Mod Pathol. 2010;23(3):470–479. doi:10.1038/modpathol.2009.180.
   PubMed Web of Science ®Google Scholar
• Butnor KJ, Pavlisko EN, Sporn TA, Roggli VL. Malignant mesothelioma in individuals with non-mesothelial neoplasms. Arch Pathol Lab Med. 2018;142(6):730–734. doi:10.5858/arpa.2017-0307-OA.
   PubMed Web of Science ®Google Scholar
• Churg A, Stevens B. Enhanced retention of asbestos fibers in the airways of human smokers. Am J Respir Crit Care Med. 1995;151(5):1409–1413. doi:10.1164/ajrccm.151.5.7735593.
   PubMed Web of Science ®Google Scholar
• Mossman BT, Churg A. State of the art: mechanisms in the pathogenesis of asbestosis and silicosis. Am J Respir Crit Care Med. 1998;157(5):1666–1680. doi:10.1164/ajrccm.157.5.9707141.
   PubMed Web of Science ®Google Scholar
• Katzenstrin A-LA. Smoking-related interstitial fibrosis (SRIF): pathologic findings and distinction from other chronic fibrosing lung diseases. J Clin Pathol. 2013;66(10):882–887. doi:10.1136/jclinpath-2012-201338.
   PubMed Web of Science ®Google Scholar
• Vehar SJ, Vadav R, Mukhopadhyay S, Nathani A, Tolle LB. Smoking-related interstitial fibrosis (SRIF) in patients presenting with diffuse parenchymal lung disease. Am J Cli Pathol. 2023;159(2):146–157. doi:10.1093/ajcp/aqac144.
   PubMed Web of Science ®Google Scholar
• Schneider F, Sporn TA, Roggli VL. Crocidolite and mesothelioma. Ultrastruct Pathol. 2008;32(5):171. doi:10.1080/01913120802343848.
   PubMed Web of Science ®Google Scholar